Abstract
Hepatitis C Virus (HCV) infection still poses a major health problem worldwide. The prevalence varies across countries with an estimated ~1% from the total population being infected. Major advancements have been made over the last years in the development of therapeutics to treat HCV infection, which are typically well-tolerated oral direct-acting antiviral (DAA) therapies with cure
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 14 Nov 2023 |
| Print ISBNs | 9789464199444 |
| Publication status | Published - 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'HCV susceptibility and host genetics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver